Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Inventory (2016 - 2024)

ENDRA Life Sciences has reported Inventory over the past 6 years, most recently at $1.3 million for Q4 2021.

  • Quarterly Inventory rose 117.87% to $1.3 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2021, up 117.87% year-over-year, with the annual reading at $1.3 million for FY2021, 117.87% up from the prior year.
  • Inventory was $1.3 million for Q4 2021 at ENDRA Life Sciences, down from $1.5 million in the prior quarter.
  • Over five years, Inventory peaked at $1.5 million in Q3 2021 and troughed at $40237.0 in Q1 2017.
  • The 5-year median for Inventory is $191680.0 (2017), against an average of $407138.5.
  • Year-over-year, Inventory surged 511.28% in 2018 and then tumbled 73.4% in 2019.
  • A 5-year view of Inventory shows it stood at $191680.0 in 2017, then tumbled by 68.99% to $59444.0 in 2018, then soared by 90.84% to $113442.0 in 2019, then skyrocketed by 419.75% to $589620.0 in 2020, then soared by 117.87% to $1.3 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Inventory are $1.3 million (Q4 2021), $1.5 million (Q3 2021), and $1.3 million (Q2 2021).